The National Institute of Health in the United States has stated that the third and final stage of trials of the Moderna vaccine against the emerging coronavirus will begin in July.
“There is a lot of optimism in our scientific community that vaccine production is possible, but we are currently focusing on supporting this with clinical trials, said John Maskula, director of vaccine research at the institute.
Initial experiments showed that the mentioned vaccine generated an immune response against the virus, the same results that were monitored in the initial trials of the vaccines AstraZenka and Johnson & Johnson.
Johnson & Johnson had announced that it would begin testing volunteers for its potential vaccine for “Covid-19” in the second half of July, two months ahead of schedule.
There are currently no approved vaccines against Covid-19 disease, caused by the emerging coronavirus, which has killed more than 400,000 people worldwide so far.